Patent · US Expired

Microbial transformation product of L-683,590

US4975372A · kind A · utility

5Cited by
1References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 13, 1989
Grant dateDec 4, 1990
Priority date
Expiry dateJan 13, 2009

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/826
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described is a new immunosuppressant, L-685,487, a monodemethylated rearranged derivative of L-683,590, produced under fermentation conditions utilizing the microorganism, unidentified Actinomycete (Merck Cultrue Collection MA 6474) ATCC No. 53828. The macrolide immunosuppressant is useful in preventing human host rejection of foreign organ transplants, e.g. bone marrow and heart transplants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.